Global Investors Learn About Region’s Cell & Gene Therapy and Connected Health Initiative at J.P. Morgan Conference in San Francisco
More than 9,000 attendees from across the globe, including industry leaders, emerging fast-growth companies, technology creators, and investors, are expected.
ChristianaCare’s Gene Editing Institute, located in Newark, Delaware, recently announced an innovation that could accelerate CRISPR gene editing work.
Greater Philadelphia Region Celebrates Momentum in Cell and Gene Therapy, Gene Editing, and Connected Health: 2019 in Review
The Greater Philadelphia region’s health care and life sciences community has much to celebrate as 2019 concludes.
2019: A Momentous Year for the Greater Philadelphia Region’s Cell & Gene Therapy and Connected Health Companies
Rapid growth and a flurry of achievements have been the hallmarks of the region’s cell & gene therapy, gene editing, and connected health companies.
Investor enthusiasm for the cell and gene therapy space is robust and growing at a breathtaking pace. From R&D through M&A, the deal data – spanning only the most recent three years – is compelling. [...]